History of creation SPE Avivac "begins in 1990, when Leningrad Region was established manufacturer of inactivated vaccines, which stood to ensure the country's poultry farms of inactivated vaccines against diseases of chickens Syndrome reductions in egg production-76.

The volume produced at the time the vaccine is 12-15 million doses per year, which fully meets the needs of poultry farms in this keenly sought after biologics.

In the future the demand for domestic production of vaccines for poultry farms has increased substantially, there is a need to live and inactivated vaccines against Newcastle disease (ND), infectious bronchitis (IBV), infectious bursal disease (IBD), reovirus tenosynovitis (REO), which was a prerequisite for expansion of the company, which was reorganized into the SPE VIROVAK "with a strong industrial base and highly skilled staff. In 2003 the company was converted into NPP Avivac.

The result was to create a modern scientific-production enterprise, which includes two main activities:



production - mass production of vaccines and diagnostic test kits series Avivac;
research - with the service laboratories and diagnostic centers.


Together with scientists from the U.S., Germany and the leading research institutes in Russia specialists SPE Avivac has designed and implemented in production facilities of diagnosis and specific prevention onkovirusnyh infection and diagnosis of avian influenza.

Currently, NPP Avivac produces more than 50 vaccines and diagnostic test systems for the poultry industry. All manufactured at the plant biologics are registered in the Russian Federation, have certificates of compliance and meet international standards.